Fast Track development of Biphasic nano-dexamethasone Pellets using galenIQ™
PharmaExcipients and Beneo proudly present the new webinar:
The low solubility of many drug active ingredients is not only challenging to formulators, but it can also mean that new effective medicines take longer to reach the market and treat the patients in need. This webinar presents a case study done in collaboration between Losan Pharma – a contract development and manufacturing organization (CDMO) and Beneo- supplier of the multifunctional excipient galenIQ™ about the development of a convenient to take once a day oral solid dosage form prototype of Dexamethasone, an active ingredient that is practically insoluble in water.
Date & Time & Timezone: 12.Okt. 2023 03:00 PM in Amsterdam, Berlin, Rom, Stockholm, Wien
Bree Warner, M.Sc., MBA
Founder / Managing Director·Genova Biosciences Inc.
Dr. Michael Black
Head of Sales Pharma Beneo
Dr. Michael Black is an organic chemist and received his Ph.D. from the University of Edinburgh in Scotland. After then doing a postdoc at the University of Florida, USA he entered the pharmaceutical industry in 1991 as an API development chemist at Boots Pharmaceuticals, UK. Since then he has remained in the pharma industry and worked in various functions such as product management for bulk Ibuprofen at Knoll, Germany, technical sales management for excipients at BASF S.E. Germany, and business development at C. F. Budenheim, Germany. Since 2014 he has been head of Sales Pharma at Beneo Palatinit GmbH, Germany.
For more information & registration here: